CorMedix Shares Surge After Beating Preliminary Q4 Revenue Estimates
Daily NewsBERKELEY HEIGHTS, N.J. - CorMedix Inc. (NASDAQ:CRMD) shares rose by 20% following the announcement of the biopharmaceutical company's preliminary fourth-quarter r...
Read More